Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma

Published:2022-08-09 Issue:1 Volume:78 Page:233-243
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Papi Alberto¹^ORCID,Corren Jonathan²,Castro Mario³,Domingo Christian⁴,Rogers Linda⁵,Chapman Kenneth R.⁶,Jackson Daniel J.⁷^ORCID,Daizadeh Nadia⁸,Pandit‐Abid Nami⁹,Gall Rebecca¹⁰,Jacob‐Nara Juby A.⁹,Rowe Paul J.⁹,Deniz Yamo¹⁰,Ortiz Benjamin¹⁰

Affiliation:

1. Respiratory Medicine, University of Ferrara and Emergency Department University Hospital Ferrara Italy

2. David Geffen School of Medicine at UCLA Los Angeles California USA

3. University of Kansas School of Medicine Kansas City Kansas USA

4. Pulmonary Service, Corporació Sanitària Parc Taulí Autonomous University of Barcelona Sabadell Barcelona Spain

5. Icahn School of Medicine at Mount Sinai New York New York USA

6. University of Toronto Toronto Ontario Canada

7. University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

8. Sanofi Cambridge Massachusetts USA

9. Sanofi Bridgewater Township New Jersey USA

10. Regeneron Pharmaceuticals, Inc. Tarrytown New York USA

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15456

Reference26 articles.

1. A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

2. A Longitudinal, Population-Based, Cohort Study of Childhood Asthma Followed to Adulthood

3. Lifetime Risk Factors for Pre- and Post-Bronchodilator Lung Function Decline. A Population-based Study

4. Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma

5. Associations between blood eosinophils and decline in lung function among adults with and without asthma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of biologics for patients with inadequately controlled asthma: A network meta-analysis;World Allergy Organization Journal;2024-07

2. Global influence of dupilumab on Quality of Life in a severe asthma patient with T2 multimorbidities: a case report on atopic dermatitis, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis;Journal of Asthma;2023-12-28

3. Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab;Life;2023-09-08

4. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis;Frontiers in Immunology;2023-04-11

5. Changes of Thymus and Activation-Regulated Chemokine in Type 2 Inflammatory Disease Patients with Dupilumab Treatment;Journal of Investigational Allergology and Clinical Immunology;2022-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3